A Resource for Healthcare and Social Services Professionals
October 26, 2018
8:00 am–4:30 pm ET
This course educates physicians, nurse practitioners, and physician assistants on prescribing buprenorphine for the treatment of opioid use disorder, with particular attention to the treatment of women during pregnancy and postpartum.
South Shore Hospital
55 Fogg Road at Route 18
Snell Conference Room
South Weymouth, MA
This free eight-hour course prepares physicians, nurse practitioners and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.
Check-in for the course will be from 7:30am to 8:00am and the training will run from 8:00am to 4:30pm. DAY OF Contact: Colleen LaBelle - Colleen.Labelle@bmc.org - 617-797-6712 Breakfast and lunch will be provided. This is an in-person training. There will not be an option to attend via webinar.
This event is to provide 8 hours of Approved Buprenorphine Waiver Training.
Upon completion of this 8 hour training, the participants will be able to:
Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Abuse Services (DPH/BSAS)
American Academy of Addiction Psychiatry (AAAP) is the Data 2000 Sponsor for this training
Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government
Method of physician participation in the learning process: Credit will only be awarded for completing all of the training. To be awarded a Buprenorphine Training Completion Certificate you must complete all 8 hours of the course. Those who finish the full course will be able to complete the waiver application online once their residency is complete.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.